BQC19 is a biobank with its own management and governance structure. The governance includes a Governing Committee, a Steering Committee, an independent Data and Sample Access Committee, and an international Scientific Advisory Board. It also includes several sub-committees responsible for mandates ranging from scientific priorities to communication and ethical, legal and social issues. The governance of BQC19 is framed in its Management Framework. Terms of References for accessing samples and data collected within the framework of BQC19 are being completed.
The BQC19 reports to the funding agencies and to the multicentric ethics committee that has approved the project. It will also have to undergo an external examination by a committee made up of international experts.
Director of the BQC19; research directors of participating institutions; a public health representative, a patient-partner representative, ethics & legal expert (see current membership below). Observers: FRQS; Genome Quebec1; PHAC.
|FRQS1||Carole Jabet, co-chair1|
|Génome Québec1||Daniel Coderre, co-chair1|
|Directeur de la BQC19||Vincent Mooser|
|CR CHUS||CIUSSS de l’Estrie - CHUS||William Fraser|
|UQAC||CIUSSS du Saguenay Lac St-Jean||Catherine Laprise|
|CR CHUSJ||CHUSJ||Jacques Michaud|
|CR CHU de Québec/Université Laval||CHU de Québec||Serge Rivest|
|CR HMR||HMR||Denis Claude Roy|
|Lady Davis institute||Jewish General Hospital||Samy Suissa|
|The Douglas Research Centre||Douglas Mental Health University Institute||Gustavo Turecki|
|McGill Vice-President Research and Innovation||Martha Crago|
|Patient-partner representative||Vincent Dumez|
|Public health representative||TBD|
|McGill Deputy VPRI, non-voting member||Philippe Gros|
|PHAC, non-voting member||Pascal Michel|
1 For the time of the BQC19 launch, GQ CEO and FRQS scientific director are interim co-chairs of the governance committee
- Define the objectives, phases and milestones of the BQC19 development as well as the performance indicators associated with each of them considering the mission of the BQC19.
- State the main priorities for the use of the BQC19, according to its strategic objectives and taking into account the public health emergency as a priority.
- Approve the BQC19 access rules.
- Ensure open and transparent participation by all research organizations and teams who would like to contribute to the collection, while respecting the Management Framework.
- Ensure the adequacy of the activities of the BQC19 in connection with its social mission and its support in responding to the health emergency
- Ensure ethical, responsible use consistent with best policy practices and cognizant of the concerns of patient-partners
- Ensure the sustainability of the BQC19 (both in terms of human and material resources, etc.).
- Ensure the periodic update of the BQC19 Management Framework, based on best practices applied in the Province and internationally (funding agency policies; laws; etc.) and inform funders.
- Receive operation reports (ask for international / independent scientific assessments if necessary) and note the achievement of objectives or formulate expectations for their future achievement.
- Formulate expectations regarding what will happen to BQC19 once its primary mission has been fulfilled and the pandemic passed (e.g.: ethical and responsible transition plan or termination).
Under the direction of Vincent Mooser, directors of all working groups in charge of operations:
|Chair||Vincent Mooser MD||McGill/CERC|
|Opérations||Dan Auld PhD||McGill/McGill Genome Centre|
|IT/Clinical Recruitment||Michael Chassé MD PhD||Université de Montréal/CHUM|
|Psycho-social||Ève Dubé PhD||Université Laval|
|Science||Daniel Kaufmann MD||Université de Montréal/CHUM|
|GQ Representative||Alexandre Montpetit PhD||Génome-Québec|
|Non-severe COVID||Alain Piché MD PHD||Université de Sherbrooke|
|Genomics & Collaborations||Brent Richards MD, MSc PhD||McGill/JGH|
|Network||Simon Rousseau PhD||McGill/MUHC|
|Communication||Karine Tremblay PhD||Université de Sherbrooke/CIUSSS-SLSJ|
|Pediatrics||Sze Man Tse MDCM MPH||Université de Montréal/CHU Sainte-Justine|
|Ethics * Law||Ma’n H. Zawati PhD||McGill/Centre of genomics & Policy|
Ensure the operations of the BQC19.
International Scientific Advisory BoardComposition
Independent international experts; names to come.
- Critically analyze the performance of the BQC19
- Report on progress and plans, particularly according to the international context
- Provide advice on further development